Obesity (the Reason) is a major health problem and obesity is more present than ever before in today’s modern society. Our lifestyles these days are just not conducive to healthy weight management, and we all spend too much time sitting behind a desk, and not enough time getting regular exercise. Many of us are so busy that we don’t even have the time to eat right.
It can be difficult to lose weight. Anyone who has tried to diet knows how difficult and frustrating the process can be and most of the times you quit and your weight it’s still the same.
Diet pills have been available for some time; but most of these drugs either didn’t work, or they did work, but the side effects and dangers were to severe.
The release of Rimonabant Acomplia now provides obese patiens with a safe and effective medical aid for weight loss.With Rimonabant Acomplia you lose weight really fast and the you didn’t gained again,at least for a couple of years.
Buy Rimonabant Acomplia because it’s the most efficient way for you to lose weight.The weight loss is real,fast and safe.
If you want to Buy Rimonabant Acomplia you can do it right here,because our blog has a contract with a very serious pharmacie.
People seeking to buy Rimonabant (Acomplia)can presently do so in one of three possible ways.
1. You can go to a doctor in a country where the sale of Rimonabant has been approved and if the doctor agrees that you would have some benefits from the Acomplia treatment(which is very very possible), the doctor will write out to you a prescription. You would then go with the prescription to a pharmacy, and buy the diet drug rimonabant.
2. You can contact an online pharmacy in a country(all over the globe) where the sale of Acomplia has been approved . Some of these are already advertising on the internet market. Of course, you will be asked to fill out a brief medical questionnaire for review by a doctor who will then decide whether to issue a prescription.
If you are in the country where the pharmacy is located, Acomplia will be expressed to you and typically will reach you in two or three days.If you reside in a country where the drug is not yet approved (like the U.S.), the online pharmacy will sent by mail to you the drug Acomplia — typically in an unmarked package — in an effort to prevent its interception by customs. The drug of course will reach you in ten days to a couple of weeks.
The U.S. Food and Drug Administration takes the position that it is illegal for a foreign pharmacy to ship drugs not approved by the FDA into the United States. Other countries may have similar laws. In practice, very few shipments are intercepted — and some online pharmacies send another package in the rare instances that this occurs.
3. You can contact an online pharmacy in a country where the sale of Acomplia is not yet approved ( Canada). Some of these also are advertising on the internet market. While the procedure for ordering the diet drug is similar to ordering from a country where Rimonabant Acomplia is legally for sale, we don’t have much information about how third-country pharmacies ( Canadian pharmacies) are filling these orders.
The European Commission publicly issued a warning to consumers last year– when Sanofi was still not authorized to sell Acomplia anywhere — that fake versions of the diet drug already were being sold over the internet market.“People who buy unlicensed and counterfeit or illicit copies of rimonabant may be putting their health at risk,” the European Commission said.
Because Acomplia is now available is big number of countries you can buy the original diet drug,because is not indicated to buy a fake which can really affect your body.
To buy Rimonabant Acomplia you have 3 option which are now knowen by you,so now the only thing you have to do is to decide of you really want to lose weight.
This articol is for our old customers who were used to come to our site and buy maternity dresses.Maybe you think what we did is strage and it’s not normal to go from selling dresses to Rimonabant.But the fact is that we did it for our customers and for all women that recentlly gave birth.
The period after you bring a baby to this world is beautiful but in the same time womens get depressed because of the way they look and they can’t enjoy that amazing period from their lifes.
We are telling you all give because it happened to us also and it’s really hard to accept the way you look.
For all this reasons we decided that the best thing we could do is telling you about Rimonabant and it’s amaizing results.
You can buy Rimonabant under the brand name Acomplia.
Acomplia is a French diet drug that is produces by Sanofi-Aventis (a popular drug company). This diet drug has proven itself to be strongly effective in helping people to lose weight. Although this medicine is generally prescribed to treat obesity, it can also be used in order to reduce the harmful risk factors that are related with weight and that could trigger severe medical desise (such as heart disorders).
This diet drug first appeared in European Union pharmacies in 2006 and has quickly increased its popularity from that moment until now. Lots of clinical trials have proven that one of three patiens who have followed a treatment with Acomplia has been able to lose 25% of their body weight without gaining any kilos for in the next few years. Most people who have been treated with this drug lost 5 inches (48 pounds).
Improvements in glucose tolerance and insulin levels were also reported. Approximately half of the people diagnosed and participated at the studies with metabolic syndrome, who received the higher 20 mg daily dose of Acomplia, no longer had this condition at the conclusion of the trial.
If you buy Acomplia,the pill does not only facilitate the ability to control your weight, but fosters the ability to fend off weight gain.
Rimonabant, discovered and produced by French pharmaceutical firm Sanofi-Avensis, is a new drug thas has shown great promise in trials for the treatment of obesity and related metabolic risk factors.
Along with effective weight loss, Rimonabant discourages bad habits like smoking. It is also an anti-smoking pill and improves HDL(good cholesterol) and triglyceride levels. This benefits diabetes and heart conditions. Usual dosage recommended is 20mg per day based on the advise of your doctor depending on your health.
Rimonabant is widely available outside the United States, including in Eurolpe for a log time now, but Sanofi Aventis pulled it back from consideration by the U.S. FDA last summer after an agency advisory panel unanimously expressed concern over the drug’s psychiatric side-effects and they refused to approve it.
Some of the side effects that can develop due to Rimonabant usage are such as insomnia, nervousness, dry mouth,unpleasant taste in the mouth. Don’t worry about Rimonabant Acomplia’s side effects, they are natural as for any diet because of the changes in your metabolism,but if you suffer from depression you should not take it.
It is always advisable to talk to your doctor as and when you experience these or any other side effects.
QUESTIONS AND ANSWERS ON THE SAFETY OF Acomplia (RIMONABANT)
As part of its continuous monitoring of medicines, the European Medicines Agency (EMEA) has
reviewed the available information on the safety of Rimonabant Acomplia (rimonabant), particularly on the
medicine’s psychiatric safety. It has concluded that Rimonabant Acomplia’s benefits continue to outweigh its
risks, but that patients with ongoing major depression or who are receiving antidepressant treatment
should not be prescribed Rimonabant Acomplia and that some of the warnings in the medicine’s prescribing
information should be strengthened.
What is Rimonabant Acomplia?
Rimonabant Acomplia is a medicine containing the active substance rimonabant. It is used together with diet
and exercise to reduce weight in adult patients who are:
• obese (very overweight) with a body mass index (BMI) greater or equal to 30 kg/m
2
, or,
• overweight (BMI greater or equal to 27 kg/m
2
) and also have other risk factors, such as type 2
diabetes or dyslipidaemia (abnormal levels of fat in their blood).
The active substance in Rimonabant Acomplia, is a cannabinoid receptor antagonist. It acts by
blocking a specific type of receptor called cannabinoid type 1 (CB1) receptors. These receptors are
found in the nervous system and are part of the system that the body uses to control food intake. By
blocking the receptors, rimonabant can help patients to reduce food intake and to lose weight. The
receptors are also found in peripheral tissues including adipocytes (fat cells).
Rimonabant Acomplia is authorised in the European Union/European Economic Area, and is marketed in 13
European countries. Rimonabant is also authorised as ZIMULTI, but this product is not marketed in
the European Union.
Why has the EMEA reviewed the medicine?
Rimonabant Acomplia received a positive opinion from the EMEA’s Committee for Medicinal Products for
Human Use (CHMP) on 27 April 2006, and a marketing authorisation from the European Commission
on 19 June 2006. During the approval procedure, the main safety issue identified with the medicine
was psychiatric side effects, especially depression. The company that makes Rimonabant Acomplia was
requested to monitor these side effects.
In June 2007, as part of its continuous monitoring of the safety of this medicine, the CHMP requested
all available information on the psychiatric safety of Rimonabant Acomplia from sanofi-aventis. The review of
this information was finalised at the CHMP meeting of 16-19 July 2007.
Which data has the CHMP reviewed?
The review included information on the psychiatric safety of Rimonabant Acomplia, focusing on cases of
depression in patients taking the medicine, including suicidal ideation (thoughts about committing
suicide) and suicide attempts. This information came both from the company’s monitoring of the use
of the medicine from its launch until 18 June 2007, and from five studies involving 781 patients taking
Rimonabant Acomplia, which have been completed since Rimonabant Acomplia was granted marketing authorisation.
What were the conclusions of the CHMP?
The CHMP concluded that the benefits of Rimonabant Acomplia continue to outweigh its risks, except in
patients with ongoing major depression and/or taking antidepressants.
Page 2
It concluded that the risk of depression is approximately doubled in patients taking Rimonabant Acomplia,
compared to obese or overweight patients not taking the medicine. In a small minority of cases, this
could lead to suicidal ideation or even suicide attempts. This doubling of the risk of depression occurs
in all types of patients; however, this risk may be increased in patients with a past history of
depression. Although this pattern of side effects is similar to what was seen during the approval
procedure of the medicine, the CHMP concluded that this increased risk is of concern, since
Rimonabant Acomplia is now being used in patients with a history of psychiatric events. This could result in
patients with depression being at risk of their disease getting worse.
The CHMP also noted that too many patients are taking Rimonabant Acomplia at the same time as
antidepressants, even though Rimonabant Acomplia is not recommended for use in patients also taking
antidepressants.
Therefore, the CHMP recommended the following changes to the medicine’s prescribing information:
• upgrading to a contraindication the warning on the use of Rimonabant Acomplia in patients with
ongoing major depression or taking antidepressants. This means that Rimonabant Acomplia must no
longer be used in these patients,
• adding a warning that treatment with Rimonabant Acomplia should be stopped if a patient develops
depression,
• including additional information on the psychiatric safety of Rimonabant Acomplia.
The Committee also requested that the company provides a letter to be sent to healthcare providers
explaining the changes in recommendations of use for Rimonabant Acomplia.
What is the advice to patients and prescribers?
• Doctors should only prescribe Rimonabant Acomplia according to the updated prescribing information.
• Patients and their family should be aware of the risk of depression in patients taking Rimonabant Acomplia,
and that patients should not take Rimonabant Acomplia if they are taking an antidepressant.
• Patients who start to experience symptoms of depression while taking Rimonabant Acomplia should consult
their doctor.
• Patients who are taking Rimonabant Acomplia and have questions or concerns should talk to their doctor or
pharmacist.